Frazier Life Sciences Management’s Mereo BioPharma MREO Stock Holding History

Frazier Life Sciences Management’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,440,112	Closed	-$19.4M	–	48
2025 Q3	$19.4M	Hold	9,440,112	–	–	0.58%	30
2025 Q2	$25.6M	Buy	9,440,112 +1,620,249	+21%	+$3.91M	1.02%	22
2025 Q1	$17.6M	Buy	7,819,863 +2,722,084	+53%	+$7.7M	0.8%	26
2024 Q4	$17.8M	Hold	5,097,779	–	–	0.74%	28
2024 Q3	$21M	Buy	5,097,779 +696,408	+16%	+$2.88M	0.84%	26
2024 Q2	$15.8M	Buy	+4,401,371	New	+$14.3M	0.74%	31

Other funds holding MREO

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return